NCT04920500 2021-06-09
Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase NA Unknown
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Fred Hutchinson Cancer Center